Exploiting Knowledge on Structure–Activity Relationships for Designing Peptidomimetics of Endogenous Peptides
Author:
Open Access
- 7 June 2021
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 9 (6) , 651
Abstract
Endogenous peptides are important mediators in cell communication, being consequently involved in many physiological processes. Their use as therapeutic agents is limited due to their poor pharmacokinetic profile. To circumvent this drawback, alternative diverse molecules based on the stereochemical features that confer their activity can be synthesized, using them as guidance; from peptide surrogates provided with a better pharmacokinetic profile, to small molecule peptidomimetics, through cyclic peptides. The design process requires a competent use of the structure-activity results available on individual peptides. Specifically, it requires synthesis and analysis of the activity of diverse analogs, biophysical information and computational work. In the present work, we show a general framework of the process and show its application to two specific examples: the design of selective AT1 antagonists of angiotensin and the design of selective B2 antagonists of bradykinin.Keywords
This publication has 98 references indexed in Scilit:
- Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential TherapeuticsJournal of Neuroendocrinology, 2012
- Investigating Endogenous Peptides and Peptidases Using PeptidomicsBiochemistry, 2011
- Backbone Alignment Modeling of the Structure–Activity Relationships of Opioid LigandsJournal of Chemical Information and Modeling, 2011
- The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injuryTrials, 2009
- Solution NMR structure determination of proteins revisitedJournal of Biomolecular NMR, 2008
- The Structure of the Neuropeptide Bradykinin Bound to the Human G‐Protein Coupled Receptor Bradykinin B2 as Determined by Solid‐State NMR SpectroscopyAngewandte Chemie International Edition, 2008
- Proteases for Processing Proneuropeptides into Peptide Neurotransmitters and HormonesAnnual Review of Pharmacology and Toxicology, 2008
- An update on non-peptide angiotensin receptor antagonists and related RAAS modulatorsLife Sciences, 2007
- An NMR, CD, Molecular Dynamics, and Fluorometric Study of the Conformation of the Bradykinin Antagonist B-9340 in Water and in Aqueous Micellar SolutionsJournal of Medicinal Chemistry, 1996
- Three-Dimensional Recognition Requirements for Angiotensin Agonists: A Novel Solution for an Old ProblemBiochemical and Biophysical Research Communications, 1993